Skip to main content

Table 1 Demographic data and underlying disorder

From: Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study

Male (n)

24

Female (n)

8

Age (years)

59.3 + 13.2

Duration of catheterization (months)

28.80 + 48.02

Underlying disease (n)

 Multiple Sclerosis

10

 Spinal Cord lesion

15

 ischemic stroke

2

 central cord syndrome

1

 Critical illness polyneuropathy

1

 Guillan-Barré-Syndrome

1

 others

2